GSO ISO 10993-1:2016

ISO 10993-1:2009
Gulf Standard   Historical · Approved on 22 December 2016

Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

GSO ISO 10993-1:2016 Files

English 21 Pages
Historical Reference Language

GSO ISO 10993-1:2016 Scope

This part of ISO 10993 describes: — the general principles governing the biological evaluation of medical devices within a risk management process; — the general categorization of devices based on the nature and duration of their contact with the body; — the evaluation of existing relevant data from all sources; — the identification of gaps in the available data set on the basis of a risk analysis; — the identification of additional data sets necessary to analyse the biological safety of the medical device; — the assessment of the biological safety of the medical device. This part of ISO 10993 does not cover testing of materials and devices that do not come into direct or indirect contact with the patient's body, nor does it cover biological hazards arising from any mechanical failure. Other parts of ISO 10993 cover specific tests, as indicated in the Foreword.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 2156:2023
 
Gulf Standard
Cosmetic Products – Natural Henna

Recently Published from Health Sector

GSO ISO/TS 24665:2025
ISO/TS 24665:2023 
Gulf Standard
Playground and recreational areas — Framework for the competence of playground inspectors and playground maintenance technicians
GSO ISO 7787-1:2025
ISO 7787-1:2016 
Gulf Standard
Dentistry — Laboratory cutters — Part 1: Steel laboratory cutters
GSO ISO 8536-13:2025
ISO 8536-13:2024 
Gulf Standard
Infusion equipment for medical use — Part 13: Graduated flow regulators for single use with fluid contact
GSO ISO 18562-3:2025
ISO 18562-3:2024 
Gulf Standard
Biocompatibility evaluation of breathing gas pathways in healthcare applications — Part 3: Tests for emissions of volatile organic substances